Neoplasms Metastasis Completed Phase 1 Trials for Everolimus (DB01590)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00426530Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast CancerTreatment